Live and recent posts from across the Fediverse tagged #regeneronpharmaceuticals, aggregated by home.social.
Sanofi Puts Up $1B to Expand Regeneron Alliance and Develop Next-Gen Dupixent
Sanofi’s partnership with Regeneron Pharmaceuticals yielded Dupixent, whose approvals in multiple indications make it one of the top…
#France #FR #Europe #EU #Sanofi #atopicdermatitis #ClinicalTrials #deals #Dupixent #immunology #inflammation #RegeneronPharmaceuticals
https://www.europesays.com/france/87887/
Sanofi Commits Up to $8 Billion to Expand Regeneron Alliance on Next-Gen Antibodies — BigGo Finance
Sanofi SA (SNY) is betting up to $8 billion that its most successful drug partnership still has room…
#France #FR #Europe #EU #Sanofi #atopicdermatitis #BelénGarijo #Dupixent #IL-13 #Jefferies #lunsekimig #RegeneronPharmaceuticals #REGN20423 #VelociSuite
https://www.europesays.com/france/87767/
Why Regeneron (REGN) Stock Is Trading Lower Today
What Happened? Shares of biotech company Regeneron (NASDAQ:REGN) fell 4% in the afternoon session after the biotechnology company…
#France #FR #Europe #EU #Sanofi #futures #indexmarketquote #indexmarketquotes #indexmarketsymbol #indexmarketsymbols #indices #RegeneronPharmaceuticals #REGN #TheGlobeandMail
https://www.europesays.com/france/87753/
Sanofi pays Dupixent partner Regeneron $1B upfront for 4 early-stage assets to ignite R&D
Sanofi is paying Regeneron $1 billion upfront to collaborate on four early-stage immunology programs, teeing the longstanding partners up…
#France #FR #Europe #EU #Sanofi #Biotech #deals #eczema #FierceBiotechHomepage #immunology #Licensingdeals #RegeneronPharmaceuticals
https://www.europesays.com/france/87502/
https://www.europesays.com/dk/166937/ Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? #CurrentRatio #FreeCashFlow #InflammatoryConditions #MetabolicDisorders #NovoNordisk #PharmaceuticalStocks #RegeneronPharmaceuticals #ShareholderEquity #TherapeuticAreas
SNY Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?
Sanofi’s SNY stock is trading above its 50-day and 200-day simple moving averages (SMAs). A stock trading above…
#France #FR #Europe #EU #Sanofi #futures #indexmarketquote #indexmarketquotes #indexmarketsymbol #indexmarketsymbols #indices #RegeneronPharmaceuticals #REGN #TheGlobeandMail
https://www.europesays.com/france/71077/
EyePoint’s Duravyu falls short to Eylea in Phase III trial
EyePoint’s stock dropped 67% after its potential Eylea (aflibercept) competitor Duravyu fell short in a Phase III trial…
#NewsBeep #News #Medication #CA #Canada #EyePoint #Health #LUGANO #Maculardegeneration #patients #PhaseIIItrial #RegeneronPharmaceuticals
https://www.newsbeep.com/ca/863221/
EyePoint’s Duravyu falls short to Eylea in Phase III trial
EyePoint’s stock dropped 67% after its potential Eylea (aflibercept) competitor Duravyu fell short in a Phase III trial…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #EyePoint #Health #LUGANO #maculardegeneration #patients #PhaseIIItrial #RegeneronPharmaceuticals
https://www.newsbeep.com/us/818237/
EyePoint’s Duravyu falls short to Eylea in Phase III trial
EyePoint’s stock dropped 67% after its potential Eylea (aflibercept) competitor Duravyu fell short in a Phase III trial…
#NewsBeep #News #Medication #EyePoint #Health #LUGANO #Maculardegeneration #Patients #PhaseIIItrial #RegeneronPharmaceuticals #UK #UnitedKingdom
https://www.newsbeep.com/uk/742415/
https://www.europesays.com/ie/644455/ EyePoint’s Duravyu falls short to Eylea in Phase III trial #Éire #EyePoint #Health #IE #Ireland #LUGANO #MacularDegeneration #Medication #patients #PhaseIIITrial #RegeneronPharmaceuticals
Samsung Biologics? No — Samchundang Pharm Reaches Landmark Settlement in Eylea Biosimilar Patent Dispute, Clearing Path for Global Commercialization
Samchundang Pharm (000250) has effectively resolved the global patent dispute surrounding its biosimilar of the macular degeneration treatment…
#EuropeSays #Korea #KR #SamsungBiologics #aflibercept #Bayer #EuropeanPatentOffice #Eylea #RegeneronPharmaceuticals #SamchundangPharm #Samsung #SCD411 #Vizempre
https://www.europesays.com/korea/122838/
Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas
With all the fretting from the pharmaceutical industry about competition from China, patent protection losses, price reduction initiatives…
#France #FR #Europe #EU #Sanofi #Astellas #BoehringerIngelheim #BristolMyersSquibb #DaiichiSankyo #Dupixent #EliLilly #FiercePharmaHomepage #NovoNordisk #pharma #QuarterlySales #RegeneronPharmaceuticals #Takeda
https://www.europesays.com/france/64664/
Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
#France #FR #Europe #EU #Sanofi #BristolMyers #initialassessment #RegeneronPharmaceuticals
https://www.europesays.com/france/60085/
https://www.europesays.com/ch/86518/ Sales for Roche’s Vabysmo rise again, but momentum is stalled #Bayer #EyeDiseases #Eylea #FiercePharmaHomepage #Ocrevus #Pharma #QuarterlySales #RegeneronPharmaceuticals #Roche #Vabysmo
Sanofi has a ‘vigorous defense planned’ for LOE of Dupixent
Normally on Big Pharma earnings calls, execs are eager to talk up their new launches and tout blockbuster…
#France #FR #Europe #EU #Sanofi #BelénGarijo #Dupixent #FiercePharmaHomepage #PatentProtection #PaulHudson #pharma #QuarterlySales #RegeneronPharmaceuticals
https://www.europesays.com/france/37338/
Regeneron (REGN) Says EMA Accepted Review for Otarmeni Application
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 10 Best Debt-Free S&P 500 Stocks to Buy Now. On…
#NewsBeep #News #Medication #AlexandriaHammond #AU #Australia #EuropeanMedicinesAgency #EuropeanUnion #genetherapy #Health #JohnNewman #MarketingAuthorizationApplication #RegeneronPharmaceuticals
https://www.newsbeep.com/au/720624/
Regeneron (REGN) Says EMA Accepted Review for Otarmeni Application
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 10 Best Debt-Free S&P 500 Stocks to Buy Now. On…
#NewsBeep #News #Medication #AlexandriaHammond #CA #Canada #EuropeanMedicinesAgency #europeanunion #Genetherapy #Health #JohnNewman #MarketingAuthorizationApplication #RegeneronPharmaceuticals
https://www.newsbeep.com/ca/720598/
https://www.europesays.com/ie/522772/ Regeneron (REGN) Says EMA Accepted Review for Otarmeni Application #AlexandriaHammond #Éire #EuropeanMedicinesAgency #EuropeanUnion #GeneTherapy #Health #IE #Ireland #JohnNewman #MarketingAuthorizationApplication #Medication #RegeneronPharmaceuticals
Sanofi Stock Falls 6% in 3 Months: Should You Buy, Sell or Hold?
Sanofi’s SNY stock has declined 5.9% in the past three months despite reporting double-digit sales and earnings growth…
#France #FR #Europe #EU #Sanofi #futures #indexmarketquote #indexmarketquotes #indexmarketsymbol #indexmarketsymbols #indices #RegeneronPharmaceuticals #REGN #TheGlobeandMail
https://www.europesays.com/france/30801/
Irish Independent : Independent | US pharma giant blames Limerick plant production pause for margin hit
AI generated summary, Read the full article for complete information.
US biotech giant Regeneron Pharmaceuticals said that unexpected repairs at its large Raheen facility in Limerick forced a temporary halt to bulk manufacturing, which in turn reduced the company’s overall profit margin, a detail it disclosed in its most recent quarterly results.
The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson
Chicago, IL – January 6, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog.…
#NewsBeep #News #Healthcare #CA #Canada #earningsgrowth #EliLilly #Health #IntuitiveSurgical #Johnson&Johnson #Medtronic #RegeneronPharmaceuticals #ZacksConsensusEstimate #ZacksEquityResearch #ZacksInvestmentResearch #ZacksRank
https://www.newsbeep.com/ca/394235/
https://www.europesays.com/uk/680093/ The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson #EarningsGrowth #EliLilly #Health #Healthcare #IntuitiveSurgical #Johnson&Johnson #Medtronic #RegeneronPharmaceuticals #UK #UnitedKingdom #ZacksConsensusEstimate #ZacksEquityResearch #ZacksInvestmentResearch #ZacksRank
The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson
Chicago, IL – January 6, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog.…
#NewsBeep #News #Healthcare #EarningsGrowth #EliLilly #Health #healthcare #IntuitiveSurgical #Johnson&Johnson #Medtronic #RegeneronPharmaceuticals #UK #UnitedKingdom #ZacksConsensusEstimate #ZacksEquityResearch #ZacksInvestmentResearch #ZacksRank
https://www.newsbeep.com/uk/356958/
https://www.europesays.com/ie/271861/ The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson #EarningsGrowth #Éire #EliLilly #Health #HealthCare #Healthcare #IE #IntuitiveSurgical #Ireland #Johnson&Johnson #Medtronic #RegeneronPharmaceuticals #ZacksConsensusEstimate #ZacksEquityResearch #ZacksInvestmentResearch #ZacksRank
Founder of #23andMe buys back company out of #bankruptcy auction
Anne #Wojcicki has been declared the winner of a bankruptcy auction for 23andMe, the #genetics testing start-up she founded, prevailing over a rival bid from #RegeneronPharmaceuticals.
#privacy #dna
After Bankruptcy, 23andMe Finds a Buyer in Regeneron—But What Happens to Your Data? https://thecyberexpress.com/regeneron-acquire-23andme/ #RegeneronPharmaceuticals #Regeneronacquire23andMe #Mergers&Aquisitions #TheCyberExpressNews #23andmeacquisition #TheCyberExpress #FirewallDaily #BusinessNews #CyberNews #Regeneron #23andme